title: Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.
abstract: (±)-3,4-Methylenedioxymethamphetamine (MDMA) is an illicit drug that evokes transporter-mediated release of serotonin (5-HT) in the brain. 5-HT transporter (SERT) proteins are also expressed in non-neural tissues (e.g., blood), and evidence suggests that MDMA targets platelet SERT to increase plasma 5-HT. Here we tested two hypotheses related to the effects of MDMA on circulating 5-HT. First, to determine if MDMA metabolites might contribute to actions of the drug in vivo, we used in vitro microdialysis in rat blood specimens to examine the effects of MDMA and its metabolites on plasma 5-HT. Second, to determine whether effects of MDMA on plasma 5-HT might be used as an index of central SERT activity, we carried out in vivo microdialysis in blood and brain after intravenous MDMA administration. The in vitro results show that test drugs evoke dose-related increases in plasma 5-HT ranging from two- to sevenfold above baseline, with MDMA and its metabolite, (±)-3,4-methylenedioxyamphetamine (MDA), producing the largest effects. The ability of MDMA and related analogs to elevate plasma 5-HT is correlated with their potency as SERT substrates in rat brain synaptosomes. The in vivo results reveal that MDMA causes concurrent increases in extracellular 5-HT in blood and brain, but there are substantial individual differences in responsiveness to the drug. Collectively, our findings indicate that MDMA and its metabolites increase plasma 5-HT by a SERT-dependent mechanism, and suggest the possibility that measures of evoked 5-HT release in blood may reflect central SERT activity.
authors.affiliation: Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Program, IMIM-Hospital del Mar Research Institute, Barcelona, Spain.
authors.forename: Samanta
authors.initials: S
authors.lastname: Yubero-Lahoz
authors.forename: Mario A
authors.initials: MA
authors.lastname: Ayestas
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Blough
authors.forename: John S
authors.initials: JS
authors.lastname: Partilla
authors.forename: Richard B
authors.initials: RB
authors.lastname: Rothman
authors.forename: Rafael
authors.initials: R
authors.lastname: de la Torre
authors.forename: Michael H
authors.initials: MH
authors.lastname: Baumann
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D017551:Microdialysis; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D021381:Protein Transport / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000097:blood* / Q000378:metabolism; D050486:Serotonin Plasma Membrane Transport Proteins / Q000097:blood* / Q000378:metabolism*
chemical_list: D050486:Serotonin Plasma Membrane Transport Proteins; D012701:Serotonin; D018817:N-Methyl-3,4-methylenedioxyamphetamine
references.citation: Neurosci Lett. 2006 Oct 9;406(3):153-8
references.pmid: 16934400
references.citation: BMJ. 1990 Jan 27;300(6719):230-5
references.pmid: 2106931
references.citation: Mol Neurobiol. 2009 Apr;39(2):73-80
references.pmid: 19199083
references.citation: J Am Acad Child Adolesc Psychiatry. 1999 Nov;38(11):1396-402
references.pmid: 10560226
references.citation: Psychopharmacology (Berl). 2005 Jul;180(3):391-8
references.pmid: 15726335
references.citation: Mol Interv. 2010 Aug;10(4):231-41
references.pmid: 20729489
references.citation: Chest. 2007 Oct;132(4):1412-3
references.pmid: 17934137
references.citation: Drug Metab Dispos. 2009 Nov;37(11):2163-70
references.pmid: 19679675
references.citation: J Neurochem. 1996 Jan;66(1):243-9
references.pmid: 8522960
references.citation: Hum Psychopharmacol. 2001 Dec;16(8):589-598
references.pmid: 12404538
references.citation: J Pharmacol Exp Ther. 2006 Aug;318(2):604-10
references.pmid: 16644904
references.citation: Hum Psychopharmacol. 2001 Dec;16(8):557-577
references.pmid: 12404536
references.citation: J Pharmacol Exp Ther. 2009 Jun;329(3):1006-15
references.pmid: 19276400
references.citation: Br J Pharmacol. 2002 Feb;135(3):649-56
references.pmid: 11834612
references.citation: Ther Drug Monit. 2008 Jun;30(3):320-32
references.pmid: 18520604
references.citation: Neuroscience. 2008 Mar 27;152(3):773-84
references.pmid: 18313226
references.citation: Curr Top Med Chem. 2010;10(15):1499-526
references.pmid: 20583995
references.citation: Psychopharmacology (Berl). 2008 Apr;197(2):263-78
references.pmid: 18074122
references.citation: Mol Pharmacol. 1993 Dec;44(6):1227-31
references.pmid: 7903417
references.citation: Br J Pharmacol. 2008 Oct;155(4):455-62
references.pmid: 18536742
references.citation: Br J Pharmacol. 2005 Jan;144(2):231-41
references.pmid: 15665862
references.citation: Ther Drug Monit. 2004 Apr;26(2):137-44
references.pmid: 15228154
references.citation: Am J Med. 1995 Sep;99(3):249-54
references.pmid: 7653484
references.citation: J Neurochem. 2010 Jan;112(2):340-55
references.pmid: 19891736
references.citation: Synapse. 2001 Jan;39(1):32-41
references.pmid: 11071707
references.citation: Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1817-21
references.pmid: 1347426
references.citation: Biol Psychiatry. 2000 Apr 1;47(7):643-9
references.pmid: 10745057
references.citation: Synapse. 2007 Nov;61(11):882-8
references.pmid: 17657807
references.citation: Thromb Res. 2007;120(6):885-92
references.pmid: 17306868
references.citation: J Pharmacol Exp Ther. 2003 Oct;307(1):138-45
references.pmid: 12954796
references.citation: Circulation. 1999 Aug 24;100(8):869-75
references.pmid: 10458725
references.citation: Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2542-6
references.pmid: 7681602
references.citation: Psychopharmacology (Berl). 2007 Jan;189(4):489-503
references.pmid: 16220332
references.citation: Psychopharmacology (Berl). 2007 Jan;189(4):407-24
references.pmid: 16541247
references.citation: Clin Exp Pharmacol Physiol. 2006 Jul;33(7):575-83
references.pmid: 16789923
references.citation: Chest. 2006 Dec;130(6):1657-63
references.pmid: 17166979
references.citation: Br J Pharmacol. 1997 Aug;121(8):1735-43
references.pmid: 9283711